HomeInsightsMarket Capitalization

Market Capitalization of Kilitch Drugs (india) Ltd

Market Capitalization of Kilitch Drugs (india) Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

Market Cap

₹ 497.02 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Kilitch Drugs (India) Ltd is ₹ 497.02 crore as of 22 Nov 24 .
  • The Market Cap of Kilitch Drugs (India) Ltd changed from ₹ 303.57 crore on March 2019 to ₹ 626.97 crore on March 2024 . This represents a CAGR of 12.85% over 6 years.
  • The Latest Trading Price of Kilitch Drugs (India) Ltd is ₹ 309.05 as of 22 Nov 15:30 .
  • The dividend payouts of Kilitch Drugs (India) Ltd changed from ₹ 0.5 to ₹ 0.5 over 2 quarters. This represents a CAGR of 0.00% .

Historical Market Cap of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Company Fundamentals for Kilitch Drugs (India) Ltd

No data available

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

Share Price

₹ 309.05

0.60 (0.19%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Kilitch Drugs (India) Ltd

1M

1Y

3Y

5Y

Monitoring Kilitch Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024309.05
21 Nov 2024308.45
19 Nov 2024311.05
18 Nov 2024315.25
14 Nov 2024332.95
13 Nov 2024328.6
12 Nov 2024301.35
11 Nov 2024301
08 Nov 2024303.55
07 Nov 2024310

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kilitch Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kilitch Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Kilitch Drugs (India) Ltd

No data available

No data available

Historical P/E Ratio of Kilitch Drugs (India) Ltd

No data available

* All values are in %

Historical Revenue of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Kilitch Drugs (India) Ltd

No data available

* All values are in

About Kilitch Drugs (India) Ltd

  • Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company.
  • The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.
  • The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.
  • Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions. The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables.

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

05 Nov 202413:41

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 202415:38

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

02 Aug 202417:27

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 27 M...

Read more

20 May 202419:21

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Fe...

Read more

01 Feb 202419:34

News

Kilitch Drugs (India) to declare Quarterly Result

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

03 Nov 202314:34

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Kilitch Drugs (India) Ltd Market Cap

What is the market cap of Kilitch Drugs (India) Ltd?

As of November 23, 2024, Kilitch Drugs (India) Ltd has a market capitalization of ₹497.02, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Kilitch Drugs (India) Ltd's market capitalization?

Kilitch Drugs (India) Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Kilitch Drugs (India) Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Kilitch Drugs (India) Ltd's market capitalization change?

Kilitch Drugs (India) Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*